Newest Innovation of CBD Infused Based Products Generating Record Revenue Potentials

Tuesday, October 24, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

PALM BEACH, Florida, October 24, 2017 /PRNewswire/ --

Key factors

driving the continued growth of the hemp/CBD/marijuana/cannabis market include innovative CBD product introductions, technological advancement in operations, premium pricing due to high energy consumption in marijuana production, rising social acceptance
of marijuana, large base of potential cannabis consumers, medical cannabis on the rise as well as a growing popular support in cannabis market. It was recent reported by Research and Markets, analysts forecast the global CBD oil market alone to grow at a CAGR of 39.19% during the period 2017-2021. Active in the industry today includes: PotNetwork Holding Inc. (OTC: POTN), Supreme Pharmaceuticals Inc. (TSX-V: FIRE) (OTC: SPRWF), Medical Marijuana, Inc. (OTC: MJNA), Hemp Inc. (OTC: HEMP), Amfil Technologies Inc. (OTC: AMFE). PotNetwork Holding Inc. (OTC: POTN) is pleased to announce that its wholly owned subsidiary, Diamond CBD, Inc., has enhanced its product line with a delicious selection of premium honey products. Among them are honey packed straws, infused with 10mg of pure natural organic CBD. With the potential healing attributes of both Cannabis and Honey known for centuries, Diamond CBD's highly anticipated Infused Honey Sticks offer a whole new tasty way to enhance wellness and boost the immune system. Comprised of 100% natural CBD and all natural honey, these delicious straws are expected to be a welcomed enhancement, providing enthusiasts with a practical and beneficial addition right upon the inevitable opening of flu season. Read this and more news for POTN at: Although THC remains a scheduled substance under current US law, the paradigm is shifting and attitudes are changing towards cannabis, due to recent research into the endocannabinoid system and the physical role it plays. Containing receptors that naturally respond to cannabinoids, the human body has in numerous studies shown to interact favorably, often enhancing the body's natural ability to fight disease and reduce symptoms. One of the major ingredients of cannabis, and the source of CBD Rich Hemp Oil, cannabidiol has been formally recognized by the US Patent Office as an "antioxidant and neuroprotectant". Filed in 1999, and published in 2003, US Patent 6630507 has recognized cannabidiol as an effective antioxidant. Antioxidants are generally useful in the treatment of oxidative diseases and are known for anti-aging effects. Treatment resistant ailments such as Alzheimer's disease, Parkinson's disease, and HIV dementia are mentioned in the abstract as potentially treatable with antioxidant CBD. Inflammatory and autoimmune diseases are also noted. Recently announced, the Company has delivered yet another impressive month of financial and industry growth. For the month of August 2017, Diamond CBD achieved record breaking revenues of $1,764,880.00, which exceeded July revenues by 20.9%. In other industry developments and market performances of note: Supreme Pharmaceuticals Inc . (TSX-V: FIRE.V) (OTC: SPRWF) yesterday announced that 7ACRES has obtained the Health Canada approvals necessary to commence cultivation at the recently completed 30,000 sq. ft. flowering rooms at the Company's Hybrid facility. The additional flowering area consists of three modular 10,000 sq. ft. flowering rooms representing the most recent innovation of 7ACRES' hybrid cultivation methodology. The additional flowering rooms increases the size of 7ACRES' flowering facility from 10,000 sq. ft. to 40,000 sq. ft. "Our mission at Supreme is to drive innovation in commercial production of legal, premium cannabis," said John Fowler CEO of Supreme. "Since inception we have focused on refining and improving our cultivation infrastructure, management systems and standard operating procedures. The operational experience we accumulated in 2016 was used to design and develop the new flowering rooms, incorporating feedback from our operators as well as our skilled team of engineers and consultants. I am proud of the progress we have made as an organization, and I'm excited to see the new levels of quality we can achieve moving forward."

Medical Marijuana Inc. (OTC: MJNA) recently announced that its subsidiary Kannaway® LLC is welcoming Robert "Bo" Brannin as its new Senior Director of Operations. In this position, Brannin will be responsible for managing every aspect of the company's supply chain operations from purchasing to inventory, production and shipping. He will bring his twenty years of experience in the operations and logistics field to assist the team in building a strong foundation as the company now prepares to establish international operations. "We are excited to bring Bo onto the executive team as Senior Director of Operations and we are more than confident that he has the experience and skills required to effectively serve all of Kannaway's loyal customers and Brand Ambassadors," said Kannaway CEO, Blake Schroeder.

Hemp Inc. (OTC: HEMP) Developments: One Step Vending, Corp. (KOSK), a holdings company specializing in market disruptive acquisitions with an emphasis on the self-serve vending market, after the recent agreement with Hemp Inc. (OTC: HEMP), for the placement of CBD products in Micro Markets network, announces the Company's decision to direct its focus on multi-billion dollar CBD products marketing and sales online as well. As hemp and marijuana-derived CBD products constitute an emerging industry with rapid growth and a multi-billion dollar market, the Company decided to dedicate part of its resources to the creation of an e-shop for the marketing and sale of selected CBD products online. The Company is already in discussions with manufacturers of CBD consumer products and is also exploring the potential to develop its own line under its own brand as revealed in previous press releases. Along with the San Diego Micro Markets on-the-spot network, the e-shop will be the vehicle for the online sale of CBD products.

Amfil Technologies Inc. (OTC: AMFE) announced this week a summary of its Fiscal Q1 2018 Financials and provide an update on Fiscal Q2 2018 progress thus far. Amfil Technologies Inc. posted revenues of $5,900,374 for our Fiscal Q1 2018 up 20,619% from Fiscal Q1 2017 which posted $28,477 in total revenue. The company saw a gross profit of $1,041,121 and a net income of $114,106. The company as at FY Q1 2018 being September 30th 2017 had $297,748 in cash, $4,286,000 in inventory and $6,734,935 in total assets. As of today, the Public Float held with DTC is 285,504,206. Common Shares Outstanding is 488,797,586 and the Authorized Share Count has been reduced down to 600,000,000 from 900,000,000. The company has been heavily reinvesting profits to fuel its expansion since Fiscal 2017. The significant profit increases posted in our recent Q1 2018 financials are a direct result of reinvesting profits to aggressively expand the Snakes & Lattes distribution business last year.

DISCLAIMER: (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated forty-nine hundred dollars for news coverage of the current press release issued by PotNetwork Holding Inc by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Contact Information: Media Contact +1(561)325-8757


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store